Standout Papers
- The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials (1994)
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology (1993)
Immediate Impact
5 by Nobel laureates 82 standout
Citing Papers
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
2019 Standout
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
2018 Standout
Works of Bengt Bergman being referenced
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
1993 Standout
Quality of Life During Chemotherapy for Small Cell Lung Cancer: II. A longitudinal study of the EORTC Core Quality of Life Questionnaire and comparison with the Sickness Impact Profile
1992
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Bengt Bergman | 9322 | 5467 | 898 | 2925 | 98 | 15.6k | |
| S Schraub | 8529 | 4756 | 582 | 3422 | 106 | 15.9k | |
| Hans‐Henning Flechtner | 8688 | 4280 | 406 | 2985 | 115 | 14.7k | |
| N. Duez | 8512 | 4448 | 375 | 4027 | 49 | 14.0k | |
| Sam H. Ahmedzai | 8819 | 4443 | 562 | 3241 | 145 | 17.3k | |
| Fumikazu Takeda | 7332 | 3651 | 329 | 2652 | 52 | 12.2k | |
| Stewart B. Fleishman | 8788 | 4442 | 393 | 2845 | 40 | 14.5k | |
| A. Cull | 10271 | 4821 | 434 | 3135 | 50 | 17.8k | |
| Darius Razavi | 8805 | 4150 | 340 | 2832 | 155 | 16.8k | |
| Andrew Bottomley | 6820 | 3912 | 403 | 2486 | 212 | 12.3k | |
| M. Klee | 8275 | 3783 | 318 | 2875 | 23 | 13.5k |
All Works
Loading papers...